Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis

Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis

Abstract Background With the advent of novel drugs improved overall survival in patients with multiple myeloma, including patients who received up-front autologous stem cell transplantation (ASCT), has been reported from several centers. Here we report on overall survival in a population-based cohor...

Full description

Bibliographic Details
Main Authors: Jon-Magnus Tangen, Geir Erland Tjønnfjord, Nina Gulbrandsen, Tobias Gedde-Dahl, Espen Stormorken, Kristina Anderson, Camilla Dao Vo, Fredrik Hellem Schjesvold, For Oslo Myeloma Center
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Cancer
Subjects:
Multiple myeloma
Autologous stem cell transplantation
Overall survival
Novel drugs
Online Access:http://link.springer.com/article/10.1186/s12885-018-4722-x

Similar Items

Similar Items